Marker Therapeutics(MRKR) - 2020 Q3 - Earnings Call Transcript

Marker Therapeutics, Inc. (NASDAQ:MRKR) Q3 2020 Earnings Conference Call November 9, 2020 5:00 PM ET Company Participants Anthony Kim - CFO Peter Hoang - President, CEO & Director Mythili Koneru - Chief Medical Officer Juan Vera - Chief Development Officer & Director Conference Call Participants Matthew Biegler - Oppenheimer Operator Good afternoon, ladies and gentlemen, and welcome to the Marker Therapeutics' conference call. [Operator Instructions]. As a reminder, this conference call is being recorded. I ...